Clinical study on treating novel coronavirus pneumonia with pulmonary fibrosis with the help of Zhuyang Bufei Chubi granule

Affiliated Hospital of Changchun University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. It was in accordance with the diagnostic criteria of Western medicine;
•2. According to the diagnostic criteria of traditional Chinese medicine;
•3. In the past one week, CT showed that there was still inflammation / pulmonary fibrosis in the lung;
•4. The age ranged from 18 to 80 years (including boundary value);
•5. Informed and voluntary consent to participate in the implementation of the program, signed informed consent.
•Only those who meet the above four requirements can be included.

•1. Patients with allergy to Chinese Herbal Pieces in the prescription;
•2. Pregnant women;
•3. Dependent on mechanical ventilation to maintain lung function, such as ventilator;
•4. Disabled people who can't complete the collection of efficacy evaluation indicators;
•5. Mental state can not cooperate, suffering from mental illness, no self-control, can not express clearly;
•6. Participating in other clinical drug trials;
•7. According to the judgment of the researchers, there will be patients with complications or poor compliance that affect the efficacy and safety evaluation.
•8. Patients who could not cooperate with the researchers to complete the follow-up.
•Any one of the above should be excluded.

发起方

Affiliated Hospital of Changchun University of Traditional Chinese Medicine